by Joseph Weber
The Food and Drug Administration has expanded its warnings on two COVID-19 vaccines regarding a rare heart side effect, mostly impacting young males.
The side effect, Myocarditis, is a type of heart inflammation that is usually mild.
Prescribing information from the two drugmakers – Moderna and Pfizer – already advises doctors about the issue. But the FDA sent letters this spring to the drugmakers, requesting they update and expand the warnings to provide more detail about the problem and to cover a larger group of patients, according to the Associated Press.
The new warning lists the risk of myocarditis as 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old. The new label also states the problem has been most common among males 12 to 24, compared to the previous one that stated it mostly occurs in 12- to 17-year-olds.
The Centers for Disease Control and Prevention previously stated there was no increased risk of myocarditis detected in government vaccine injury databases for COVID-19 shots dating back to 2022, the wire service also reports.
– – –
Joseph Weber is a reporter for Just the News.
The post FDA Requires Drugmakers Update, Expand Warning About COVID Shots’ Heart Risks first appeared on The Arizona Sun Times.
Click this link for the original source of this article.
Author: Just the News
This content is courtesy of, and owned and copyrighted by, https://arizonasuntimes.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
